Reversible posterior leukoencephalopathy syndrome induced by bevacizumab plus chemotherapy in colorectal cancer

doi:10.3748/wjg.v20.i21.6691

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 21

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7116)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series.

Item

Count

PDF

377

WORD

183

HTML

4130

Figures (1-4)

292

Sum=4982

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1232

Download

902

Sum=2134

Jun 7, 2014 (publication date) through Mar 2, 2025

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Jun 7, 2014; 20(21): 6691-6697
Published online Jun 7, 2014. doi: 10.3748/wjg.v20.i21.6691

Full Size Figure Download Figure

Figure 4 Repeat enhanced computed tomography and magnetic resonance venography scan of the brain of case 2 on the following day showed the same image changes as previously described.

Citation: Wang W, Zhao LR, Lin XQ, Feng F. Reversible posterior leukoencephalopathy syndrome induced by bevacizumab plus chemotherapy in colorectal cancer. World J Gastroenterol 2014; 20(21): 6691-6697
URL: https://www.wjgnet.com/1007-9327/full/v20/i21/6691.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i21.6691